- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05212077
Effect of Advanced Care at Home vs. Traditional Brick-and-Mortar Hospital Care in Acutely Ill Adults: A Randomized Clinical Trial
March 11, 2024 updated by: Xiaoxi Yao, Mayo Clinic
The purpose of this study is to compare two care delivery models that are currently being implemented in routine practice settings.
The findings from this study will inform future clinical decision making, such as which patients might be more suited for which care delivery model.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85054
- Mayo Clinic Arizona
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic Jacksonville
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Wisconsin
-
Eau Claire, Wisconsin, United States, 54703
- Mayo Clinic Health System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adult patients, 18 years of age and older.
- Present to one of the participating hospitals.
- Have a chief complaint of one of the target diagnoses.
- Are within a certain geographical area (based on zip codes).
- Have a health insurance plan that covers ACH services.
- Have the capacity to consent or could assent with the consent of a health care proxy who is physically present.
Exclusion Criteria:
The patient is not suitable for ACH or inpatient hospital care based on:
- being a nursing home patient;
- on or requiring dialysis;
- positive for COVID-19;
- having discharge order;
- requiring intensive care unit (ICU) level of care;
- history of drug abuse.
- Patients will also need to meet the clinical stability criteria.
- Do not have the capacity to consent or assent with the assistance of a health care proxy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Advanced Care at Home (ACH)
Patients will receive inpatient hospitalization at home.
|
Inpatient hospitalization offered in the home setting.
|
|
Active Comparator: Traditional Inpatient (Brick-and-Mortar) Hospital Care
Patients will receive inpatient hospitalization at the hospital.
|
Inpatient hospitalization offered in the hospital setting.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary outcome is a composite outcome of all-cause mortality
Time Frame: 30 days post-discharge
|
The rate of death
|
30 days post-discharge
|
|
30-day readmission.
Time Frame: 30 days post-discharge
|
readmission between discharge from ACH/traditional inpatient hospital care and 30 days post-discharge.
|
30 days post-discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 15, 2022
Primary Completion (Actual)
December 5, 2023
Study Completion (Actual)
December 5, 2023
Study Registration Dates
First Submitted
January 26, 2022
First Submitted That Met QC Criteria
January 26, 2022
First Posted (Actual)
January 27, 2022
Study Record Updates
Last Update Posted (Actual)
March 13, 2024
Last Update Submitted That Met QC Criteria
March 11, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 21-005335
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Advanced Care at Home (ACH)
-
Mayo ClinicCompleted
-
BeLong ChoRecruitingSupportive CareKorea, Republic of
-
Lawson Health Research InstituteCardiac Arrhythmia Network of CanadaCompleted
-
Massachusetts General HospitalMedically HomeActive, not recruitingLymphoma | Head and Neck Cancer | Pancreatic Cancer | Rectal Cancer | GastroEsophageal CancerUnited States
-
Massachusetts General HospitalRetirement Research FoundationCompletedQuality of Life | Dementia | Caregiver StressUnited States
-
Massachusetts General HospitalMedically HomeCompleted
-
Massachusetts General HospitalMedically Home Group, Inc.Completed
-
Georgetown UniversityNational Cancer Institute (NCI)Completed
-
Essentia HealthMedica Sur Clinic & FoundationCompletedPulmonary Disease Chronic ObstructiveUnited States
-
Brigham and Women's HospitalBoston Medical Center; Cambridge Health AllianceActive, not recruiting